News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Posts of category: Publications

Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.

Published

September 21, 2026

Category

Publications

Nebulized nintedanib (AP02) for idiopathic pulmonary fibrosis demonstrates favorable safety and lung lining fluid exposures: results from two phase I safety, tolerability, and pharmacokinetics studies

Published

September 9, 2026

Category

Publications

Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial

Published

April 7, 2025

Category

Publications

Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment

Published

February 27, 2025

Category

Publications

Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution

Published

November 29, 2023

Category

Publications

Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial.